China Pharma Holdings (CPHI) EBITDA Margin (QoQ) (2010 - 2026)
China Pharma Holdings (CPHI) EBITDA Margin (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | China Pharma Holdings | 19.13 Mn | 18.97 Mn | 285,487.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,303.00 |
| Dec 31, 2025 | -661.00 |
| Sep 30, 2025 | -2,903.00 |
| Jun 30, 2025 | 1,894.00 |
| Mar 31, 2025 | 5,740.00 |
| Dec 31, 2024 | -3,677.00 |
| Sep 30, 2024 | 7,130.00 |
| Jun 30, 2024 | -8,905.00 |
| Mar 31, 2024 | -1,989.00 |
| Dec 31, 2023 | -1,230.00 |
| Sep 30, 2023 | 6,256.00 |
| Jun 30, 2023 | -8,791.00 |
| Mar 31, 2023 | 2,319.00 |
| Dec 31, 2022 | 3,370.00 |
| Sep 30, 2022 | 2,324.00 |
| Jun 30, 2022 | -3,297.00 |
| Mar 31, 2022 | -3,200.00 |
| Dec 31, 2021 | 1,471.00 |
| Sep 30, 2021 | -1,713.00 |
| Jun 30, 2021 | 901.00 |